Trials / Completed
CompletedNCT04905589
Medium Chain Triglycerides (MCT) and Whey Protein Isolate (WPI) for Type 2 Diabetes Patients (Combine)
Effect of Combined Intake of Medium Chain Triglycerides (MCT) At Breakfast and Whey Protein Isolate (WPI) Preload At Lunch and Dinner on Diurnal Glucose and Satiety
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of effect on diurnal glycaemia following consumption of MCT and whey protein in patients with type 2 diabetes
Detailed description
The purpose of this study (Combine) is to evaluate the effects of Combined Intake of Medium chain triglycerides (MCT) at breakfast and whey protein isolate (WPI) preload at lunch and dinner for patients with type 2 diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | BetaQuik™ | MCT (Medium chain triglycerides) |
| DIETARY_SUPPLEMENT | WheyBasics | Whey Protein Isolate |
| OTHER | Iso-voluminous water | Iso-voluminous Water as comparitor to Betaquik or WheyBasics |
Timeline
- Start date
- 2021-04-30
- Primary completion
- 2022-08-01
- Completion
- 2022-08-01
- First posted
- 2021-05-27
- Last updated
- 2024-10-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04905589. Inclusion in this directory is not an endorsement.